ישראל - עברית - Ministry of Health

lapidot medical import and marketing ltd - deferiprone - טבליות מצופות פילם - deferiprone 500 mg - deferiprone - deferiprone - for the treatment of iron overload in patients over 6 years old with thalassaemia major when deferoxamine therapy is contraindicated or inadequate.

ישראל - עברית - Ministry of Health

lapidot medical import and marketing ltd - deferiprone - תמיסה (פומי) - deferiprone 100 mg / 1 ml - deferiprone - deferiprone - for the treatment of iron overload in patients over 6 years old with thalassaemia major when deferoxamine therapy is contraindicated or inadequate.

ישראל - עברית - Ministry of Health

lapidot medical import and marketing ltd - deferiprone - טבליות מצופות פילם - deferiprone 1000 mg - deferiprone

ישראל - עברית - Ministry of Health

taro pharmaceutical industries ltd - deferiprone - טבליה - deferiprone 500 mg - deferiprone

ישראל - עברית - Ministry of Health

taro pharmaceutical industries ltd - deferiprone - טבליות מצופות פילם - deferiprone 1000 mg - deferiprone

ישראל - עברית - Ministry of Health

novartis israel ltd - deferasirox - טבליות ניתנות לפיזור - deferasirox 125 mg - deferasirox - deferasirox - exjade is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adult and pediatric patients (aged 2 years and over).exjade is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older. chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration (lic) >5 mg fe/g dry weight (dw) following mri and serum ferritin >800 nanogram/ml).

ישראל - עברית - Ministry of Health

novartis israel ltd - deferasirox - טבליות ניתנות לפיזור - deferasirox 500 mg - deferasirox - deferasirox - exjade is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adult and pediatric patients (aged 2 years and over).exjade is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older. chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration (lic) >5 mg fe/g dry weight (dw) following mri and serum ferritin >800 nanogram/ml).

ישראל - עברית - Ministry of Health

novartis israel ltd - deferasirox - טבליות ניתנות לפיזור - deferasirox 250 mg - deferasirox - deferasirox - exjade is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adult and pediatric patients (aged 2 years and over).exjade is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older. chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration (lic) >5 mg fe/g dry weight (dw) following mri and serum ferritin >800 nanogram/ml).

ישראל - עברית - Ministry of Health

teva israel ltd - deferasirox - טבליות ניתנות לפיזור - deferasirox 125 mg - deferasirox

ישראל - עברית - Ministry of Health

teva israel ltd - deferasirox - טבליות ניתנות לפיזור - deferasirox 250 mg - deferasirox